Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients.
Eur J Cancer. 2000 Jan;36(1):43-8. doi: 10.1016/s0959-8049(99)00225-7.
Eur J Cancer. 2000.
PMID: 10741293
Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF.
Poikonen P, Saarto T, Lundin J, Joensuu H, Blomqvist C.
Poikonen P, et al.
Br J Cancer. 1999 Aug;80(11):1763-6. doi: 10.1038/sj.bjc.6690594.
Br J Cancer. 1999.
PMID: 10468293
Free PMC article.
Clinical Trial.
Item in Clipboard
Effect of obesity on the leukocyte nadir in women treated with adjuvant cyclophosphamide, methotrexate, and fluorouracil dosed according to body surface area.
Poikonen P, Blomqvist C, Joensuu H.
Poikonen P, et al.
Acta Oncol. 2001;40(1):67-71. doi: 10.1080/028418601750071082.
Acta Oncol. 2001.
PMID: 11321664
Item in Clipboard
Skin toxicity as a risk factor for major infections in breast cancer patients treated with docetaxel.
Poikonen P, Sjöström J, Klaar S, Nittby LT, Sigurdsson H, Madsen EL, Joensuu H, Blomqvist C.
Poikonen P, et al.
Acta Oncol. 2004;43(2):190-5. doi: 10.1080/02841860310022977.
Acta Oncol. 2004.
PMID: 15163169
Clinical Trial.
Item in Clipboard
Cyclin A as a marker for prognosis and chemotherapy response in advanced breast cancer.
Poikonen P, Sjöström J, Amini RM, Villman K, Ahlgren J, Blomqvist C.
Poikonen P, et al.
Br J Cancer. 2005 Sep 5;93(5):515-9. doi: 10.1038/sj.bjc.6602735.
Br J Cancer. 2005.
PMID: 16091759
Free PMC article.
Clinical Trial.
Item in Clipboard
Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
Joensuu H, Kellokumpu-Lehtinen PL, Huovinen R, Jukkola-Vuorinen A, Tanner M, Kokko R, Ahlgren J, Auvinen P, Paija O, Helle L, Villman K, Nyandoto P, Nilsson G, Pajunen M, Asola R, Poikonen P, Leinonen M, Kataja V, Bono P, Lindman H.
Joensuu H, et al. Among authors: poikonen p.
J Clin Oncol. 2012 Jan 1;30(1):11-8. doi: 10.1200/JCO.2011.35.4639. Epub 2011 Nov 21.
J Clin Oncol. 2012.
PMID: 22105826
Clinical Trial.
Item in Clipboard
Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial.
Joensuu H, Kellokumpu-Lehtinen PL, Huovinen R, Jukkola-Vuorinen A, Tanner M, Asola R, Kokko R, Ahlgren J, Auvinen P, Hemminki A, Paija O, Helle L, Nuortio L, Villman K, Nilsson G, Lahtela SL, Lehtiö K, Pajunen M, Poikonen P, Nyandoto P, Kataja V, Bono P, Leinonen M, Lindman H; FinXX Study Investigators.
Joensuu H, et al. Among authors: poikonen p.
Lancet Oncol. 2009 Dec;10(12):1145-51. doi: 10.1016/S1470-2045(09)70307-9. Epub 2009 Nov 10.
Lancet Oncol. 2009.
PMID: 19906561
Clinical Trial.
Item in Clipboard
Cite
Cite